Exodus Point Capital Management, LP Veracyte, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 114,840 shares of VCYT stock, worth $3.49 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
114,840
Previous 734,448
84.36%
Holding current value
$3.49 Million
Previous $25 Million
81.81%
% of portfolio
0.03%
Previous 0.15%
Shares
13 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
80.4MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$249 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$237 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$200 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$128 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$124 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.17B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...